Published in PLoS Pathog on September 15, 2016
Functional RNA structures throughout the Hepatitis C Virus genome. Curr Opin Virol (2017) 0.75
Characterization of HCV envelope diversification from acute to chronic infection using SMRT sequencing within a sexually-transmitted hepatitis C virus cluster. J Virol (2017) 0.75
Short-Sighted Virus Evolution and a Germline Hypothesis for Chronic Viral Infections. Trends Microbiol (2017) 0.75
Accurate quantification of within- and between-host HBV evolutionary rates requires explicit transmission chain modelling. Virus Evol (2017) 0.75
MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol (2011) 220.97
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (1995) 34.97
DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics (2003) 32.63
Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol (2012) 32.00
Viral dynamics in human immunodeficiency virus type 1 infection. Nature (1995) 28.54
Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med (2011) 19.01
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A (2008) 16.54
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science (1998) 10.43
Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol (1999) 10.41
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. N Engl J Med (2009) 10.21
Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology (2003) 7.35
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science (2000) 5.49
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol (2009) 4.40
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc Natl Acad Sci U S A (2005) 3.94
Viral mutation rates. J Virol (2010) 3.87
Clonal interference and the evolution of RNA viruses. Science (1999) 3.68
Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology (2008) 3.09
Visualizing hepatitis C virus infections in human liver by two-photon microscopy. Gastroenterology (2009) 3.07
Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol (1994) 2.53
Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation. J Hepatol (2005) 2.39
The origin of hepatitis C virus genotypes. J Gen Virol (1997) 2.26
Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comput Biol (2007) 2.25
Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study. Lancet (2015) 2.18
Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver. Hepatology (2014) 1.89
Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression. Mol Biol Evol (2003) 1.89
Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy. J Theor Biol (2007) 1.89
"Lifespan" of liver cells. Autoradio-graphic study using tritiated thymidine in normal, cirrhotic, and partially hepatectomized rats. Arch Intern Med (1961) 1.83
Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study. Lancet Infect Dis (2015) 1.78
Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration. J Virol (2002) 1.75
Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission. J Virol (2010) 1.67
Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients. Hepatology (2008) 1.64
Effect of ribavirin on the mutation rate and spectrum of hepatitis C virus in vivo. J Virol (2009) 1.58
Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production. Gastroenterology (2005) 1.47
Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J Virol (1999) 1.42
Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol (2005) 1.41
Focal distribution of hepatitis C virus RNA in infected livers. PLoS One (2009) 1.32
Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol (1998) 1.31
Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate. PLoS Pathog (2012) 1.30
Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver. Gastroenterology (2013) 1.23
Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver. J Virol (2000) 1.23
Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver. Hepatology (1999) 1.19
The genealogical population dynamics of HIV-1 in a large transmission chain: bridging within and among host evolutionary rates. PLoS Comput Biol (2014) 1.18
Temporal variations in the hepatitis C virus intrahost population during chronic infection. J Virol (2011) 1.15
A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1. J Hepatol (2013) 1.12
Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively. Proc Natl Acad Sci U S A (2006) 1.11
Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection. Hepatology (2007) 1.10
In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease. J Virol (2000) 1.09
Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma. J Gen Virol (1997) 1.08
Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathway. Oncogene (2005) 1.05
A new evolutionary model for hepatitis C virus chronic infection. PLoS Pathog (2012) 1.02
Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis. Proc Natl Acad Sci U S A (2012) 1.01
Compartmentalization of hepatitis C virus quasispecies in blood mononuclear cells of patients with mixed cryoglobulinemic syndrome. J Virol (2005) 0.99
Population genomics of intrapatient HIV-1 evolution. Elife (2015) 0.99
Passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts. J Virol (2006) 0.98
Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response. Gastroenterology (2012) 0.98
Hepatitis C virus compartmentalization and infection recurrence after liver transplantation. Am J Transplant (2009) 0.94
Evolutionary analysis of hepatitis C virus gene sequences from 1953. Philos Trans R Soc Lond B Biol Sci (2013) 0.92
Quasispecies of hepatitis C virus in serum and in three different parts of the liver of patients with chronic hepatitis. Hepatology (1999) 0.92
Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue. Proc Natl Acad Sci U S A (2016) 0.90
Early infection events highlight the limited transmissibility of hepatitis C virus in vitro. J Hepatol (2013) 0.90
Hepatitis C virus quasispecies in cancerous and noncancerous hepatic lesions: the core protein-encoding region. Acta Med Okayama (2002) 0.90
Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C. Antivir Ther (2013) 0.90
Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C. Virology (2008) 0.89
Comparative sequence analysis of the core- and NS5-region of hepatitis C virus from tumor and adjacent non-tumor tissue. J Med Virol (2001) 0.88
Divergent evolution of hepatitis C virus in liver and peripheral blood mononuclear cells of infected patients. J Med Virol (1999) 0.87
Intra-host evolutionary dynamics of hepatitis C virus E2 in treated patients. J Gen Virol (2005) 0.86
Unexpected maintenance of hepatitis C viral diversity following liver transplantation. J Virol (2012) 0.86
Inferring viral dynamics in chronically HCV infected patients from the spatial distribution of infected hepatocytes. PLoS Comput Biol (2014) 0.86
Differences between hepatitis C virus 5' untranslated region quasispecies in serum and liver. J Gen Virol (1999) 0.85
Coalescent Inference Using Serially Sampled, High-Throughput Sequencing Data from Intrahost HIV Infection. Genetics (2016) 0.81
Very late HCV relapse following triple therapy for hepatitis C. Antivir Ther (2014) 0.77
Persistence of Hepatitis C Virus Traces after Spontaneous Resolution of Hepatitis C. PLoS One (2015) 0.76
Synthesis and anti-HCV entry activity studies of β-cyclodextrin-pentacyclic triterpene conjugates. ChemMedChem (2014) 0.76
Comprehensive cloning of patient-derived 9022-bp amplicons of hepatitis C virus. J Virol Methods (2013) 0.76
Plasma and liver hepatitis C virus variability in patients coinfected with human immunodeficiency virus. J Clin Microbiol (2006) 0.76
Autophagy is a critical regulator of memory CD8(+) T cell formation. Elife (2014) 1.76
Unifying viral genetics and human transportation data to predict the global transmission dynamics of human influenza H3N2. PLoS Pathog (2014) 1.72
Molecular Epidemiology and Evolution of Influenza Viruses Circulating within European Swine between 2009 and 2013. J Virol (2015) 1.43
Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS One (2013) 1.06
Virus evolution and transmission in an ever more connected world. Proc Biol Sci (2015) 1.03
CD39 Expression Identifies Terminally Exhausted CD8+ T Cells. PLoS Pathog (2015) 0.96
Global migration of influenza A viruses in swine. Nat Commun (2015) 0.96
Contribution of Epidemiological Predictors in Unraveling the Phylogeographic History of HIV-1 Subtype C in Brazil. J Virol (2015) 0.84
Intercontinental dispersal of HIV-1 subtype B associated with transmission among men who have sex with men in Japan. J Virol (2014) 0.84
Occurrence and reassortment of avian influenza A (H7N9) viruses derived from coinfected birds in China. J Virol (2014) 0.83
Bayesian Inference Reveals Host-Specific Contributions to the Epidemic Expansion of Influenza A H5N1. Mol Biol Evol (2015) 0.82
Characterization of Hepatitis C Virus Recombination in Cameroon by Use of Nonspecific Next-Generation Sequencing. J Clin Microbiol (2015) 0.81
Coalescent Inference Using Serially Sampled, High-Throughput Sequencing Data from Intrahost HIV Infection. Genetics (2016) 0.81
HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer. J Virol (2016) 0.78
Differential infection patterns and recent evolutionary origins of equine hepaciviruses in donkeys. J Virol (2016) 0.77
Genome Sequence of a Candidate World Health Organization Reference Strain of Zika Virus for Nucleic Acid Testing. Genome Announc (2016) 0.77
Genealogical Working Distributions for Bayesian Model Testing with Phylogenetic Uncertainty. Syst Biol (2015) 0.77
Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in Korea. PLoS One (2017) 0.75
Characterization of HCV envelope diversification from acute to chronic infection using SMRT sequencing within a sexually-transmitted hepatitis C virus cluster. J Virol (2017) 0.75
A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+ T Helper Cells to Confirm B Cell Activation. PLoS One (2016) 0.75
Increasing airline travel may facilitate co-circulation of multiple dengue virus serotypes in Asia. PLoS Negl Trop Dis (2017) 0.75
Genomic and epidemiological characterisation of a dengue virus outbreak among blood donors in Brazil. Sci Rep (2017) 0.75
Using viral gene sequences to compare and explain the heterogeneous spatial dynamics of virus epidemics. Mol Biol Evol (2017) 0.75
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis. Joint Bone Spine (2017) 0.75
Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR. EBioMedicine (2020) 0.75
Epidemiological and ecological determinants of Zika virus transmission in an urban setting. Elife (2017) 0.75
Science Forum: The Human Cell Atlas. Elife (2017) 0.75